A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells

類似資料

• Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer
  著者:: Kala, Rishabh, 等
  出版事項: (2015)
• Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression
  著者:: Li, Yuanyuan, 等
  出版事項: (2017)
• Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
  著者:: Li, Yuanyuan, 等
  出版事項: (2013)
• Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells
  著者:: Li, Yuanyuan, 等
  出版事項: (2010)
• Epigenetic reactivation of p21(CIP1/WAF1) and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells
  著者:: Sinha, Sonam, 等
  出版事項: (2015)